Close Menu

NEW YORK (GenomeWeb) – Biocept said in a regulatory filing today that it has amended a previous prospectus filed in November with the US Securities and Exchange Commission to now offer about 3.6 million shares of its common stock as well as warrants to purchase another 3.6 million shares at an assumed combined price of $2.11 per share and related warrant.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New research shows that scientists need to do a better job of including a wider diversity of African genomes in their analyses, STAT says.

A new paper in Science shows that men are still winning a large majority of the most sought-after NIH grants.

Nature Research and the Estée Lauder Companies are awarding efforts to encourage girls to pursue careers in the STEM fields.

In Science this week: beneficial genetic variants inherited from archaic Neanderthal and Denisovan hominins, and more.